Home Clinical Trials Browse by State Browse by City Hepatitis C Guides About Contact

🧪 Paid Hepatitis C Clinical Trials

Browse recruiting hepatitis c clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Hepatitis C
Condition

Active Clinical Trials for Hepatitis C

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Hepatitis C

Hepatitis C is a viral infection causing liver inflammation that can become chronic and lead to cirrhosis or liver cancer. Clinical trials investigate new antiviral therapies, treatment-shortening regimens, and approaches for hard-to-treat populations.

Common Symptoms

Fatigue, fever, nausea, poor appetite, abdominal pain, dark urine, clay-colored stools, joint pain, jaundice

Risk Factors

IV drug use, blood transfusion before 1992, needlestick injuries, hemodialysis, HIV co-infection, born to infected mother

Treatment Overview

Treatment includes direct-acting antiviral (DAA) medications that can cure most cases. Clinical trials explore pangenotypic regimens, shorter treatment durations, and strategies for eliminating hepatitis C globally.

Why Participate?

Hepatitis C clinical trials help develop more accessible and shorter treatment regimens, contributing to the global goal of eliminating hepatitis C as a public health threat.

Related Conditions

States with Hepatitis C Clinical Trials

Cities with Hepatitis C Clinical Trials

Frequently Asked Questions About Hepatitis C Clinical Trials

Hepatitis C clinical trials test new antiviral medications and treatment approaches to improve cure rates and reduce treatment duration.
Eligibility depends on hepatitis C genotype, viral load, liver function, prior treatment history, and whether cirrhosis is present.
Compensation varies. Participants may receive $50-$200 per visit with study medications and monitoring provided at no cost.
Yes, participants receive regular monitoring of liver function and viral levels. All trials follow strict safety protocols.